152 related articles for article (PubMed ID: 1895159)
1. A monoclonal antibody (ERIC-1), raised against retinoblastoma, that recognizes the neural cell adhesion molecule (NCAM) expressed on brain and tumours arising from the neuroectoderm.
Bourne SP; Patel K; Walsh F; Popham CJ; Coakham HB; Kemshead JT
J Neurooncol; 1991 Apr; 10(2):111-9. PubMed ID: 1895159
[No Abstract] [Full Text] [Related]
2. Monoclonal antibody UJ13A recognizes the neural cell adhesion molecule (NCAM).
Patel K; Rossell RJ; Bourne S; Moore SE; Walsh FS; Kemshead JT
Int J Cancer; 1989 Dec; 44(6):1062-8. PubMed ID: 2558078
[TBL] [Abstract][Full Text] [Related]
3. A monoclonal antibody to a cytoskeletal protein selectively recognizing malignant neuroectodermal tumors.
Chakrabarti SK; Sil M; Poddar R; Sarkar PK
Hybridoma; 1994 Dec; 13(6):491-7. PubMed ID: 7737673
[TBL] [Abstract][Full Text] [Related]
4. Antiretinoblastoma monoclonal antibodies.
Char DH; Rand N; Howes EL; Lyon H; Morita CT
Retina; 1983; 3(3):200-5. PubMed ID: 6356261
[TBL] [Abstract][Full Text] [Related]
5. Production and characterization of monoclonal antibodies recognising defined regions of the human oestrogen receptor.
Ali S; Lutz Y; Bellocq JP; Chenard-Neu MP; Rouyer N; Metzger D
Hybridoma; 1993 Aug; 12(4):391-405. PubMed ID: 7503939
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a monoclonal antibody recognizing a 138 kDa glioblastoma-associated antigen.
Klaich GM; Kanter PM
Anticancer Drugs; 1995 Feb; 6(1):45-52. PubMed ID: 7756683
[TBL] [Abstract][Full Text] [Related]
7. Common neuroectodermal antigens on human melanoma, neuroblastoma, retinoblastoma, glioblastoma and fetal brain revealed by hybridoma antibodies raised against melanoma cells.
Liao SK; Clarke BJ; Kwong PC; Brickenden A; Gallic BL; Dent PB
Eur J Immunol; 1981 Jun; 11(6):450-4. PubMed ID: 7262181
[TBL] [Abstract][Full Text] [Related]
8. Human monoclonal antibodies.
Kan-Mitchell J; Mitchell MS
Prog Clin Biol Res; 1989; 288():85-94. PubMed ID: 2717643
[No Abstract] [Full Text] [Related]
9. Expression of alternative isoforms of the neural cell adhesion molecule (NCAM) on normal brain and a variety of brain tumours.
Frost G; Patel K; Bourne S; Coakham HB; Kemshead JT
Neuropathol Appl Neurobiol; 1991 Jun; 17(3):207-17. PubMed ID: 1891065
[TBL] [Abstract][Full Text] [Related]
10. [Preparation of anti-human retinoblastoma monoclonal antibody by solid tumor cell immunization and study on characteristics of its antigen].
Zhong X; Li Y; Ning B; Yan J; Li Y; Luo G; Lin J; Ying F; Feng G
Zhonghua Yan Ke Za Zhi; 2002 Nov; 38(11):691-4. PubMed ID: 12487903
[TBL] [Abstract][Full Text] [Related]
11. Description of a new monoclonal antibody, FC-2.15, reactive with human breast cancer and other human neoplasias.
Mordoh J; Leis S; Bravo AI; Podhajcer OL; Ballare C; Capurro M; Kairiyama C; Bover L
Int J Biol Markers; 1994; 9(3):125-34. PubMed ID: 7829891
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody SEN7 recognizes a new epitope on the neural cell adhesion molecule present on small cell lung cancer but not on lymphocytes.
Waibel R; Mannhart M; O'Hara CJ; Brocklehurst C; Zangemeister-Wittke U; Schenker T; Lehmann HP; Weber E; Stahel RA
Cancer Res; 1993 Jun; 53(12):2840-5. PubMed ID: 7684948
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody 3F8 recognises the neural cell adhesion molecule (NCAM) in addition to the ganglioside GD2.
Patel K; Rossell RJ; Pemberton LF; Cheung NK; Walsh FS; Moore SE; Sugimoto T; Kemshead JT
Br J Cancer; 1989 Dec; 60(6):861-6. PubMed ID: 2481486
[TBL] [Abstract][Full Text] [Related]
14. Neural cell adhesion molecule (NCAM) is the antigen recognized by monoclonal antibodies of similar specificity in small-cell lung carcinoma and neuroblastoma.
Patel K; Moore SE; Dickson G; Rossell RJ; Beverley PC; Kemshead JT; Walsh FS
Int J Cancer; 1989 Oct; 44(4):573-8. PubMed ID: 2551826
[TBL] [Abstract][Full Text] [Related]
15. Biological characterization and clinical applications of a monoclonal antibody recognizing an antigen restricted to neuroectodermal tissues.
Allan PM; Garson JA; Harper EI; Asser U; Coakham HB; Brownell B; Kemshead JT
Int J Cancer; 1983 May; 31(5):591-8. PubMed ID: 6852977
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin superfamily expression in primary retinoblastoma and retinoblastoma cell lines.
Madigan MC; Penfold PL; King NJ; Billson FA; Conway RM
Oncol Res; 2002; 13(2):103-11. PubMed ID: 12392158
[TBL] [Abstract][Full Text] [Related]
17. Retinoblastoma: tissue culture lines and monoclonal antibody studies.
Char DH; Wood IS; Huhta K; Rand N; Morita CT; Howes EL
Invest Ophthalmol Vis Sci; 1984 Jan; 25(1):30-40. PubMed ID: 6199320
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the colorectal antigen IOR C2.II.
Vázquez AM; Tormo B; Velandia A; Gómez CA; Alfonso M; Giscombe R; Ansotegui I; Jeddi-Tehrani M; Pérez R; Mellstedt H
Year Immunol; 1993; 7():137-45. PubMed ID: 7690506
[No Abstract] [Full Text] [Related]
19. Blockade of natural killer cell-mediated lysis by NCAM140 expressed on tumor cells.
Jarahian M; Watzl C; Issa Y; Altevogt P; Momburg F
Int J Cancer; 2007 Jun; 120(12):2625-34. PubMed ID: 17294447
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies against human malignant melanoma.
Sorg C; Brüggen J; Suter L; Bröcker EB
Bull Cancer; 1983; 70(2):113-7. PubMed ID: 6871486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
